{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-006760","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2022-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.945868+00:00","generated_at":"2026-06-26T21:50:54.581904+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BioLife Solutions receives Nasdaq delisting notice for delayed 10-K filing","bullets":["Received Nasdaq notice on March 17, 2022 for failure to timely file 2021 10-K.","Has until May 16, 2022 to submit a plan to regain compliance.","If plan accepted, Nasdaq may grant extension until September 12, 2022.","CFO states Form 10-K expected to be filed no later than March 31, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-006760","json":"https://secwatch.observer/filing/0001437749-22-006760.json","markdown":"https://secwatch.observer/filing/0001437749-22-006760.md","text":"https://secwatch.observer/filing/0001437749-22-006760.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000143774922006760/0001437749-22-006760-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000143774922006760/bioli20220318_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T21:50:54.581904+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}